Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
CellVec Pte Ltd
Singapore
C
11-50 Employees
2018
Key takeaway
CellVec is a certified GMP gene therapy CDMO that specializes in providing custom viral vectors for both pre-clinical and clinical applications. Their advanced manufacturing facility and innovative CellVec Vector Platform enable them to address technological challenges in the production of viral vectors, making them well-equipped to support the development of in vivo gene therapies.
Reference
Core business
CellVec | Innovation for Patient Benefit
A certified GMP gene therapy CDMO that is a specialist provider of custom viral vectors for pre-clinical and clinical applications
Research Instruments Pte Ltd
Singapore
C
51-100 Employees
1989
Key takeaway
Everlife-Research Instruments is dedicated to providing advanced research tools and solutions that could support the scientific community's efforts in areas like in vivo gene therapy. Their commitment to innovation and efficiency may enhance research capabilities in this field.
Reference
Product
Cell and Gene Therapy – Research Instruments Pte Ltd
Tessa Therapeutics
Singapore
C
101-250 Employees
2001
Key takeaway
Tessa Therapeutics is focused on developing innovative cell therapies for cancer, including a unique allogeneic CD30-CAR EBVST platform that targets various cancers. Their approach to cancer immunotherapy leverages the body's anti-viral immune response, which may have implications for in vivo gene therapy strategies.
Reference
Product
Technology | Tessa Therapeutics – Cancer Immunotherapy Treatments
A comprehensive approach to cancer immunotherapy. Successful cancer immunotherapy treatments mimic core aspects of the body’s anti-viral immune response.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Clearbridge Medical Group
Singapore
C
11-50 Employees
-
Key takeaway
The company is focused on enhancing early disease detection and personalized disease management, which may relate to the identification of genetic risk factors relevant to in vivo gene therapy.
Reference
Product
Gene.X Brochure | Clearbridge Medical Group
Gene.X Brochure
Macrogen Asia Pacific Pte. Ltd.
Singapore
C
11-50 Employees
-
Key takeaway
Macrogen APAC is a leading provider of genomics services, offering advanced techniques such as Next Generation Sequencing and Capillary Electrophoresis Sequencing. Their expertise in genomics includes research services and clinical diagnostics, which may support applications in areas like in vivo gene therapy.
Reference
Core business
Precision Medicine, Genomics Services Singapore - Macrogen Asia Pacific Pte Ltd
Research services include Next Generation Sequencing, Capillary Electrophoresis Sequencing, Microarrays, Transgenic mice, Oligonucleotide synthesis. Clinical services include hereditary cancer testing, somatic cancer panels, carrier testing, NIPT screening, clinical WGS and clinical WES.
Advanced Cell Therapy and Research Institute Singapore
Singapore
C
51-100 Employees
2020
Key takeaway
ACTRIS is focused on advancing cellular-based therapeutics, which includes a commitment to process development and manufacturing of therapies relevant to immunotherapy and regenerative medicine. Their goal to achieve regulatory accreditation ensures quality compliance in the production of cellular therapies, making them a key player in the field of therapeutic innovation.
Reference
Service
Our Services | Cell Therapy Manufacturing and Process Development
Genedant
Singapore
C
1-10 Employees
2020
Key takeaway
Genedant is focused on investing in early-stage, deep-tech start-ups in the biomedical sector, emphasizing their commitment to innovative science and technology that challenges conventional thinking. Their dedication to supporting visionary thinkers and clinicians aligns with the pursuit of transformative advancements, potentially relevant to in vivo gene therapy developments.
Reference
Core business
Genedant
Genedant invests in emerging science and technology ventures that challenges conventional thinking of what is possible.
Guardant Health AMEA
Singapore
C
11-50 Employees
2018
Key takeaway
Guardant Health AMEA is focused on advancing cancer treatment through innovative solutions that utilize blood tests to provide critical molecular information. Their collaboration with pharmaceutical companies aims to discover new therapeutic approaches, ultimately improving patient outcomes in cancer care.
Reference
Core business
Guiding Cancer Treatment | Liquid Biopsy - Guardant360
Guardant Health AMEA is dedicated to helping cancer patients get the right treatment. Contact us to learn more about the new cancer treatment in Singapore.
iGene Laboratory
Singapore
C
51-100 Employees
2014
Key takeaway
The text does not provide information about in vivo gene therapy.
Reference
Core business
iGene Laboratory — iGene Laboratory
INEX Innovations Exchange
Singapore
C
11-50 Employees
2006
Key takeaway
INEX Innovate is a research-driven company that focuses on developing innovative diagnostic technologies, including their patented LEXI® methodology for isolating fetal cells from maternal blood. Their commitment to addressing unmet clinical needs in women's and fetal health highlights their role in advancing precision healthcare.
Reference
Core business
INEX Innovate — INEX Innovate
Technologies which have been searched by others and may be interesting for you:
When exploring the In Vivo Gene Therapy industry in Singapore, several key considerations arise. The regulatory landscape is critical, as the Health Sciences Authority (HSA) oversees the approval process for gene therapies, ensuring compliance with stringent safety and efficacy standards. Researchers and companies must navigate these regulations while remaining aware of potential challenges such as funding limitations and the technical complexities of developing effective gene delivery systems. Singapore offers a supportive ecosystem with substantial government funding and incentives aimed at fostering innovation in biotechnology, presenting numerous opportunities for growth. Collaborations with academic institutions and access to advanced research facilities further bolster the industry. Environmental concerns related to gene therapy, such as the management of genetically modified organisms, also require careful attention. The competitive landscape is dynamic, with both local startups and established multinational companies vying for market share, necessitating a thorough analysis of their strengths and weaknesses. Lastly, the global market relevance cannot be understated, as Singapore positions itself as a hub for biotechnology in Asia, attracting international partnerships and investments that enhance its standing in the global gene therapy market. Understanding these factors will provide a solid foundation for anyone interested in this evolving field.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Singapore |
| Amount of fitting manufacturers | 43 |
| Amount of suitable service providers | 21 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1989 |
| Youngest suiting company | 2020 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Other, Healthcare, Medical, IT, Software and Services
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.